How does the therapeutic anti-IL-4 receptor dupilumab relieve atopic dermatitis? Imai et al. demonstrate that this drug improves symptoms via suppression and alteration of Th2 cells and ILC2s in patients with atopic dermatitis. http://bit.ly/jididup #JIDInnovations #dermscience
Min Ma will present her @JExpMed article: "Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis" in the next #ESDRKitchen webinar on 21 April!